Role of copper in regression of cardiac hypertrophy

Pharmacology and Therapeutics

Volumn 148, Issue , 2015, Pages 66-84

  Zheng, Lily ^a   Han, Pengfei ^a   Liu, Jiaming ^a   Li, Rui ^a   Yin, Wen ^a   Wang, Tao ^a   Zhang, Wenjing ^a   James Kang, Y ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

Angiogenesis; Cardiac hypertrophy; CCO; Copper; VEGFRs HIF 1

Indexed keywords

CHAPERONE; CHELATING AGENT; COPPER; CYTOCHROME C OXIDASE; HYPOXIA INDUCIBLE FACTOR 1; METALLOCHAPERONE; SILDENAFIL; SIMVASTATIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COPPER DEFICIENCY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOXIA; MINERAL SUPPLEMENTATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; ANIMAL; CARDIOMEGALY; METABOLISM;

ANIMALS; CARDIOMEGALY; COPPER; ELECTRON TRANSPORT COMPLEX IV; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84923294934     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.11.014     Document Type: Review

References (318)

1. Z. Ahmed, B.D. Idowu, and R.A. Brown Stabilization of fibronectin mats with micromolar concentrations of copper Biomaterials 20 1999 201 209
2. R. Albin, R.T. Dowell, R. Zak, and M. Rabinowitz Synthesis and degradation of mitochondrial components in hypertrophied rat heart Biochem J 136 1973 629 637
3. G. Alessandri, K. Raju, and P.M. Gullino Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin-copper complex Microcirc Endothel Lymphat 1 1984 329 346
4. C.L. Antos, T.A. McKinsey, N. Frey, W. Kutschke, J. McAnally, and J.M. Shelton Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo Proc Natl Acad Sci 99 2002 907 912
5. M.D. Apostolova, P.R. Bontchev, B.B. Ivanova, W.R. Russell, D.R. Mehandjiev, and J.H. Beattie Copper-homocysteine complexes and potential physiological actions J Inorg Biochem 95 2003 321 333
6. Z. Arany, S.Y. Foo, Y. Ma, J.L. Ruas, A. Bommi-Reddy, and G. Girnun HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha Nature 451 2008 1008 1012
7. Z. Arany, L.E. Huang, R. Eckner, S. Bhattacharya, C. Jiang, and M.A. Goldberg An essential role for p300/CBP in the cellular response to hypoxia Proc Natl Acad Sci U S A 93 1996 12969 12973
8. A.G. Arroyo, and M.L. Iruela-Arispe Extracellular matrix, inflammation, and the angiogenic response Cardiovasc Res 86 2010 226 235
9. T. Ashino, V. Sudhahar, N. Urao, J. Oshikawa, G.F. Chen, and H. Wang Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration Circ Res 107 2010 787 799
10. H.G. Augustin, G.Y. Koh, G. Thurston, and K. Alitalo Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system Nat Rev Mol Cell Biol 10 2009 165 177
11. S. Banerjee, S. Mehta, I. Haque, K. Sengupta, K. Dhar, and S. Kambhampati VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis Biochemistry 47 2008 3345 3351
12. B. Bartling, H. Milting, H. Schumann, D. Darmer, L. Arusoglu, and M.M. Koerner Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure Circulation 100 1999 II216 II223
13. T.B. Bartnikas, and J.D. Gitlin How to make a metalloprotein Nat Struct Biol 8 2001 733 734
14. E.J. Battegay, J. Rupp, L. Iruela-Arispe, E.H. Sage, and M. Pech PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors J Cell Biol 125 1994 917 928
15. J. Beers, D.M. Glerum, and A. Tzagoloff Purification, characterization, and localization of yeast Cox17p, a mitochondrial copper shuttle J Biol Chem 272 1997 33191 33196
16. K. Bentley, G. Mariggi, H. Gerhardt, and P.A. Bates Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis PLoS Comput Biol 5 2009 e1000549
17. E. Berra, G. Pages, and J. Pouyssegur MAP kinases and hypoxia in the control of VEGF expression Cancer Metastasis Rev 19 2000 139 145
18. A.M. Bode, L.A. Miller, J. Faber, and J.T. Saari Mitochondrial respiration in heart, liver, and kidney of copper-deficient rats J Nutr Biochem 3 1992 668 672
19. M.O. Boluyt, J.S. Zheng, A. Younes, X. Long, L. O'Neill, and H. Silverman Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase Circ Res 81 1997 176 186
20. S. Brem, S.A. Grossman, K.A. Carson, P. New, S. Phuphanich, and J.B. Alavi Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma Neuro Oncol 7 2005 246 253
21. S.S. Brem, D. Zagzag, A.M. Tsanaclis, S. Gately, M.P. Elkouby, and S.E. Brien Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor Am J Pathol 137 1990 1121 1142
22. G.J. Brewer Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer Curr Cancer Drug Targets 5 2005 195 202
23. G.J. Brewer, R.D. Dick, D.K. Grover, V. LeClaire, M. Tseng, and M. Wicha Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study Clin Cancer Res 6 2000 1 10
24. C.G. Brilla, and B. Maisch Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure Eur Heart J 15 Suppl. D 1994 45 52
25. A. Buchwald, H. Till, C. Unterberg, R. Oberschmidt, H.R. Figulla, and V. Wiegand Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy Eur Heart J 11 1990 509 516
26. H. Bugger, M. Schwarzer, D. Chen, A. Schrepper, P.A. Amorim, and M. Schoepe Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure Cardiovasc Res 85 2010 376 384
27. M.W. Calhoun, J.W. Thomas, and R.B. Gennis The cytochrome oxidase superfamily of redox-driven proton pumps Trends Biochem Sci 19 1994 325 330
28. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
29. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
30. P. Carmeliet, Y. Dor, J.M. Herbert, D. Fukumura, K. Brusselmans, and M. Dewerchin Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Nature 394 1998 485 490
31. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, and M. Gertsenstein Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
32. P. Carmeliet, Y.S. Ng, D. Nuyens, G. Theilmeier, K. Brusselmans, and I. Cornelissen Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 Nat Med 5 1999 495 502
33. H.S. Carr, G.N. George, and D.R. Winge Yeast Cox11, a protein essential for cytochrome c oxidase assembly, is a Cu(I)-binding protein J Biol Chem 277 2002 31237 31242
34. H.S. Carr, and D.R. Winge Assembly of cytochrome c oxidase within the mitochondrion Acc Chem Res 36 2003 309 316
35. C. Carrasco-Pozo, A. Alvarez-Lueje, C. Olea-Azar, C. Lopez-Alarcon, and H. Speisky In vitro interaction between homocysteine and copper ions: potential redox implications Exp Biol Med (Maywood) 231 2006 1569 1575
36. J.C. Chao, D.M. Medeiros, J. Davidson, and L. Shiry Low levels of ATP synthase and cytochrome c oxidase subunit peptide from hearts of copper-deficient rats are not altered by the administration of dimethyl sulfoxide J Nutr 124 1994 789 803
37. J.C. Chappell, and V.L. Bautch Vascular development: genetic mechanisms and links to vascular disease Curr Top Dev Biol 90 2010 43 72
38. X. Chen, D.B. Jennings, and D.M. Medeiros Impaired cardiac mitochondrial membrane potential and respiration in copper-deficient rats J Bioenerg Biomembr 34 2002 397 406
39. B. Chipperfield, and J.R. Chipperfield Differences in metal content of the heart muscle in death from ischemic heart disease Am Heart J 95 1978 732 737
40. P.A. Cobine, F. Pierrel, and D.R. Winge Copper trafficking to the mitochondrion and assembly of copper metalloenzymes Biochim Biophys Acta Mol Cell Res 1763 2006 759 772
41. E.M. Conway, D. Collen, and P. Carmeliet Molecular mechanisms of blood vessel growth Cardiovasc Res 49 2001 507 521
42. G.J. Cooper, A.R. Phillips, S.Y. Choong, B.L. Leonard, D.J. Crossman, and D.H. Brunton Regeneration of the heart in diabetes by selective copper chelation Diabetes 53 2004 2501 2508
43. G.J. Cooper, A.A. Young, G.D. Gamble, C.J. Occleshaw, A.M. Dissanayake, and B.R. Cowan A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study Diabetologia 52 2009 715 722
44. W.F. Coulson, and W.H. Carnes Cardiovascular studies on copper-deficient swine. V. The histogenesis of the coronary artery lesions Am J Pathol 43 1963 945 954
45. M.J. Cross, and L. Claesson-Welsh FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition Trends Pharmacol Sci 22 2001 201 207
46. V.C. Culotta, L.W. Klomp, J. Strain, R.L. Casareno, B. Krems, and J.D. Gitlin The copper chaperone for superoxide dismutase J Biol Chem 272 1997 23469 23472
47. D.F. Dai, E.J. Hsieh, Y. Liu, T. Chen, R.P. Beyer, and M.T. Chin Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress Cardiovasc Res 93 2012 79 88
48. P.R. Dallman Cytochrome oxidase repair during treatment of copper deficiency: relation to mitochondrial turnover J Clin Invest 46 1967 1819 1827
49. J. Davidson, D.M. Medeiros, and R.L. Hamlin Cardiac ultrastructural and electrophysiological abnormalities in postweanling copper-restricted and copper-repleted rats in the absence of hypertrophy J Nutr 122 1992 1566 1575
50. J. De Freitas, H. Wintz, J.H. Kim, H. Poynton, T. Fox, and C. Vulpe Yeast, a model organism for iron and copper metabolism studies Biometals 16 2003 185 197
51. F. De Smet, I. Segura, K. De Bock, P.J. Hohensinner, and P. Carmeliet Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way Arterioscler Thromb Vasc Biol 29 2009 639 649
52. B. DeBosch, I. Treskov, T.S. Lupu, C. Weinheimer, A. Kovacs, and M. Courtois Akt1 is required for physiological cardiac growth Circulation 113 2006 2097 2104
53. J. Diez, B. Lopez, A. Gonzalez, and R. Querejeta Clinical aspects of hypertensive myocardial fibrosis Curr Opin Cardiol 16 2001 328 335
54. O. Distler, J.H. Distler, A. Scheid, T. Acker, A. Hirth, and J. Rethage Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis Circ Res 95 2004 109 116
55. M. Dobaczewski, W. Chen, and N.G. Frangogiannis Transforming growth factor (TGF)-beta signaling in cardiac remodeling J Mol Cell Cardiol 51 2011 600 606
56. D. Dong, B. Wang, W. Yin, X. Ding, J. Yu, and Y.J. Kang Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury PLoS ONE 8 2013 e76209
57. G.W. Dorn, and T. Force Protein kinase cascades in the regulation of cardiac hypertrophy J Clin Invest 115 2005 527 537
58. N.P. Dudman, and D.E. Wilcken Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency Clin Chim Acta 127 1983 105 113
59. D.J. Dumont, L. Jussila, J. Taipale, A. Lymboussaki, T. Mustonen, and K. Pajusola Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 Science 282 1998 946 949
60. H. Eckardt, K.G. Bundgaard, K.S. Christensen, M. Lind, E.S. Hansen, and I. Hvid Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis J Orthop Res 21 2003 335 340
61. B.P. Eliceiri, R. Paul, P.L. Schwartzberg, J.D. Hood, J. Leng, and D.A. Cheresh Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability Mol Cell 4 1999 915 924
62. L. Elsherif, Y. Jiang, J.T. Saari, and Y.J. Kang Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion Exp Biol Med (Maywood) 229 2004 616 622
63. L. Elsherif, R.V. Ortines, J.T. Saari, and Y.J. Kang Congestive heart failure in copper-deficient mice Exp Biol Med (Maywood) 228 2003 811 817
64. L. Elsherif, L. Wang, J.T. Saari, and Y.J. Kang Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice J Nutr 134 2004 855 860
65. A.M. Emsley, J.Y. Jeremy, G.N. Gomes, G.D. Angelini, and F. Plane Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta Br J Pharmacol 126 1999 1034 1040
66. K.A. Engleka, and T. Maciag Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation J Biol Chem 267 1992 11307 11315
67. E. Fassone, J.W. Taanman, I.P. Hargreaves, N.J. Sebire, M.A. Cleary, and M. Burch Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy J Med Genet 48 2011 691 697
68. W. Feng, F. Ye, W. Xue, Z. Zhou, and Y.J. Kang Copper regulation of hypoxia-inducible factor-1 activity Mol Pharmacol 75 2009 174 182
69. N. Ferrara Role of vascular endothelial growth factor in the regulation of angiogenesis Kidney Int 56 1999 794 814
70. N. Ferrara, and K. Alitalo Clinical applications of angiogenic growth factors and their inhibitors Nat Med 5 1999 1359 1364
71. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, and K.S. O'Shea Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 1996 439 442
72. B. Fiedler, S.M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, and F. Schroder Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes Proc Natl Acad Sci U S A 99 2002 11363 11368
73. M. Flesch, K.B. Margulies, H.C. Mochmann, D. Engel, N. Sivasubramanian, and D.L. Mann Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading Circulation 104 2001 2273 2276
74. G.H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
75. G.-H. Fong, L. Zhang, D.-M. Bryce, and J. Peng Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice Development 126 1999 3015 3025
76. P. Freisinger, R. Horvath, C. Macmillan, J. Peters, and M. Jaksch Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper? J Inherit Metab Dis 27 2004 67 79
77. T.G. Frey, and J.M. Murray Electron microscopy of cytochrome c oxidase crystals. Monomer-dimer relationship and cytochrome c binding site J Mol Biol 237 1994 275 297
78. N.W. Gale, and G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev 13 1999 1055 1066
79. A. Garnier, D. Fortin, C. Delomenie, I. Momken, V. Veksler, and R. Ventura-Clapier Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles J Physiol 551 2003 491 501
80. H.P. Gerber, K.J. Hillan, A.M. Ryan, J. Kowalski, G.A. Keller, and L. Rangell VEGF is required for growth and survival in neonatal mice Development 126 1999 1149 1159
81. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, and A. Abramsson VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 2003 1163 1177
82. A. Ghosh, P.P. Trivedi, S.A. Timbalia, A.T. Griffin, J.J. Rahn, and S.S. Chan Copper supplementation restores cytochrome c oxidase assembly defect in a mitochondrial disease model of COA6 deficiency Hum Mol Genet 23 2014 3596 3606
83. H. Gille, J. Kowalski, L. Yu, H. Chen, M.T. Pisabarro, and T. Davis-Smyth A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration EMBO J 19 2000 4064 4073
84. D.M. Glerum, A. Shtanko, and A. Tzagoloff Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase J Biol Chem 271 1996 14504 14509
85. D.M. Glerum, A. Shtanko, and A. Tzagoloff SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae J Biol Chem 271 1996 20531 20535
86. V.L. Goodman, G.J. Brewer, and S.D. Merajver Copper deficiency as an anti-cancer strategy Endocrinol Relat Cancer 11 2004 255 263
87. J.R. Goodman, J.B. Warshaw, and P.R. Dallman Cardiac hypertrophy in rats with iron and copper deficiency: quantitative contribution of mitochondrial enlargement Pediatr Res 4 1970 244 256
88. R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
89. S. Gupta, D. Young, R.K. Maitra, A. Gupta, Z.B. Popovic, and S.L. Yong Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB J Mol Biol 375 2008 637 649
90. H. Haddad, W. Elabbassi, S. Moustafa, R. Davies, T. Mesana, and P. Hendry Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension ASAIO J 51 2005 456 460
91. S. Hamasaki, J. Al Suwaidi, S.T. Higano, K. Miyauchi, D.R. Holmes Jr., and A. Lerman Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy J Am Coll Cardiol 35 2000 1654 1660
92. G.N. Hannan, and B.R. McAuslan Modulation of synthesis of specific proteins in endothelial cells by copper, cadmium, and disulfiram: an early response to an angiogenic inducer of cell migration J Cell Physiol 111 1982 207 212
93. H. Hao, L. Zhang, S. Jiang, S. Sun, P. Gong, and Y. Xie Thioacetamide intoxication triggers transcriptional up-regulation but enzyme inactivation of UDP-glucuronosyltransferases Drug Metab Dispos 39 2011 1815 1822
94. M. Harada, Y. Takeishi, T. Arimoto, T. Niizeki, T. Kitahara, and K. Goto Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy Circ J 71 2007 276 282
95. J.D. Harding, V. Piacentino III, J.P. Gaughan, S.R. Houser, and K.B. Margulies Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure Circulation 104 2001 1241 1247
96. P.M. Heerdt, J.W. Holmes, B. Cai, A. Barbone, J.D. Madigan, and S. Reiken Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure Circulation 102 2000 2713 2719
97. J. Heineke, M. Auger-Messier, R.N. Correll, J. Xu, M.J. Benard, and W. Yuan CIB1 is a regulator of pathological cardiac hypertrophy Nat Med 16 2010 872 879
98. J. Heineke, and J.D. Molkentin Regulation of cardiac hypertrophy by intracellular signalling pathways Nat Rev Mol Cell Biol 7 2006 589 600
99. R. Henderson, R.A. Capaldi, and J.S. Leigh Arrangement of cytochrome oxidase molecules in two-dimensional vesicle crystals J Mol Biol 112 1977 631 648
100. N.L. Henry, R. Dunn, S. Merjaver, Q. Pan, K.J. Pienta, and G. Brewer Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer Oncology 71 2006 168 175
101. J.C. Hershey, E.P. Baskin, H.A. Corcoran, A. Bett, N.M. Dougherty, and D.B. Gilberto Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits Heart Vessels 18 2003 142 149
102. S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice Proc Natl Acad Sci 95 1998 9349 9354
103. M. Hirsila, P. Koivunen, L. Xu, T. Seeley, K.I. Kivirikko, and J. Myllyharju Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway FASEB J 19 2005 1308 1310
104. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol Rev 56 2004 549 580
105. R. Holtwick, M. van Eickels, B.V. Skryabin, H.A. Baba, A. Bubikat, and F. Begrow Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A J Clin Invest 111 2003 1399 1407
106. J.K. Hon, and M.H. Yacoub Bridge to recovery with the use of left ventricular assist device and clenbuterol Ann Thorac Surg 75 2003 S36 S41
107. D. Horn, and A. Barrientos Mitochondrial copper metabolism and delivery to cytochrome c oxidase IUBMB Life 60 2008 421 429
108. J. Hou, and Y.J. Kang Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets Pharmacol Ther 135 2012 337 354
109. G.F. Hu Copper stimulates proliferation of human endothelial cells under culture J Cell Biochem 69 1998 326 335
110. C. Hu, A. Dandapat, J. Chen, Y. Fujita, N. Inoue, and Y. Kawase LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion Cardiovasc Res 76 2007 292 302
111. H. Huang, A. Bhat, G. Woodnutt, and R. Lappe Targeting the ANGPT-TIE2 pathway in malignancy Nat Rev Cancer 10 2010 575 585
112. 2-dependent degradation domain via the ubiquitin-proteasome pathway Proc Natl Acad Sci U S A 95 1998 7987 7992
113. W.M. Hughes Jr., W.E. Rodriguez, D. Rosenberger, J. Chen, U. Sen, and N. Tyagi Role of copper and homocysteine in pressure overload heart failure Cardiovasc Toxicol 8 2008 137 144
114. Y. Huo, C.O. Linares, and G.S. Kassab Capillary perfusion and wall shear stress are restored in the coronary circulation of hypertrophic right ventricle Circ Res 100 2007 273 283
115. J.S. Ingwall, and R.G. Weiss Is the failing heart energy starved? On using chemical energy to support cardiac function Circ Res 95 2004 135 145
116. S. Itoh, H.W. Kim, O. Nakagawa, K. Ozumi, S.M. Lessner, and H. Aoki Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation J Biol Chem 283 2008 9157 9167
117. 2 sensing Science 292 2001 464 468
118. K. Iwai, K. Yamanaka, T. Kamura, N. Minato, R.C. Conaway, and J.W. Conaway Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex Proc Natl Acad Sci U S A 96 1999 12436 12441
119. S. Iwata Structure and function of bacterial cytochrome c oxidase J Biochem 123 1998 369 375
120. Y. Izumiya, I. Shiojima, K. Sato, D.B. Sawyer, W.S. Colucci, and K. Walsh Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload Hypertension 47 2006 887 893
121. 2-regulated prolyl hydroxylation Science 292 2001 468 472
122. L. Jakobsson, C.A. Franco, K. Bentley, R.T. Collins, B. Ponsioen, and I.M. Aspalter Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting Nat Cell Biol 12 2010 943 953
123. M. Jaksch, R. Horvath, N. Horn, D.P. Auer, C. Macmillan, and J. Peters Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy Neurology 57 2001 1440 1446
124. M. Jaksch, I. Ogilvie, J. Yao, G. Kortenhaus, H.G. Bresser, and K.D. Gerbitz Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency Hum Mol Genet 9 2000 795 801
125. M. Jeansson, A. Gawlik, G. Anderson, C. Li, D. Kerjaschki, and M. Henkelman Angiopoietin-1 is essential in mouse vasculature during development and in response to injury J Clin Invest 121 2011 2278 2289
126. J.Y. Jeremy, N. Shukla, G.D. Angelini, A. Day, I.Y. Wan, and S.P. Talpahewa Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting Ann Thorac Surg 74 2002 1553 1557
127. Y. Jiang, C. Reynolds, C. Xiao, W. Feng, Z. Zhou, and W. Rodriguez Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice J Exp Med 204 2007 657 666
128. B.H. Jiang, J.Z. Zheng, S.W. Leung, R. Roe, and G.L. Semenza Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension J Biol Chem 272 1997 19253 19260
129. W.T. Johnson, and H.M. Brown-Borg Cardiac cytochrome-c oxidase deficiency occurs during late postnatal development in progeny of copper-deficient rats Exp Biol Med (Maywood) 231 2006 172 180
130. M. Jullig, A.J. Hickey, C.C. Chai, G.L. Skea, M.J. Middleditch, and S. Costa Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats Proteomics 8 2008 2556 2572
131. P.J. Kallio, K. Okamoto, S. O'Brien, P. Carrero, Y. Makino, and H. Tanaka Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha EMBO J 17 1998 6573 6586
132. Y.J. Kang Copper and homocysteine in cardiovascular diseases Pharmacol Ther 129 2011 321 331
133. Y.J. Kang, H. Wu, and J.T. Saari Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart Proc Soc Exp Biol Med 223 2000 282 287
134. R. Karch, F. Neumann, R. Ullrich, J. Neumuller, B.K. Podesser, and M. Neumann The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy Cardiovasc Pathol 14 2005 135 144
135. T. Karpanen, M. Bry, H.M. Ollila, T. Seppanen-Laakso, E. Liimatta, and H. Leskinen Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy Circ Res 103 2008 1018 1026
136. E. Kaza, K. Ablasser, D. Poutias, E.R. Griffiths, F.A. Saad, and J.G. Hofstaetter Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium Cardiovasc Res 89 2011 410 418
137. Q. Ke, T. Kluz, and M. Costa Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line Int J Environ Res Public Health 2 2005 10 13
138. O. Khalimonchuk, and G. Rodel Biogenesis of cytochrome c oxidase Mitochondrion 5 2005 363 388
139. M.K. Khan, M.W. Miller, J. Taylor, N.K. Gill, R.D. Dick, and K. Van Golen Radiotherapy and antiangiogenic TM in lung cancer Neoplasia 4 2002 164 170
140. B.E. Kim, T. Nevitt, and D.J. Thiele Mechanisms for copper acquisition, distribution and regulation Nat Chem Biol 4 2008 176 185
141. D.A. Kimball, W.F. Coulson, and W.H. Carnes Cardiovascular studies on copper-deficient swine. III. Properties of isolated aortic elastin Exp Mol Pathol 33 1964 10 18
142. S. Kliche, and J. Waltenberger VEGF receptor signaling and endothelial function IUBMB Life 52 2001 61 66
143. A.A. Knowlton, L. Chen, and Z.A. Malik Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies J Cardiovasc Pharmacol 63 2014 196 206
144. T. Kohno, N. Urao, T. Ashino, V. Sudhahar, R.D. McKinney, and T. Hamakubo Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury Arterioscler Thromb Vasc Biol 33 2013 805 813
145. N. Koitabashi, T. Aiba, G.G. Hesketh, J. Rowell, M. Zhang, and E. Takimoto Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation. Novel mechanism of cardiac stress modulation by PDE5 inhibition J Mol Cell Cardiol 48 2010 713 724
146. S. Koneru, S. Varma Penumathsa, M. Thirunavukkarasu, R. Vidavalur, L. Zhan, and P.K. Singal Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1 J Cell Mol Med 12 2008 2651 2664
147. S.J. Kopp, L.M. Klevay, and J.M. Feliksik Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency Am J Physiol 245 1983 H855 H866
148. S. Krick, B.G. Eul, J. Hanze, R. Savai, F. Grimminger, and W. Seeger Role of hypoxia-inducible factor-1alpha in hypoxia-induced apoptosis of primary alveolar epithelial type II cells Am J Respir Cell Mol Biol 32 2005 395 403
149. G. Krummeck, and G. Rodel Yeast SCO1 protein is required for a post-translational step in the accumulation of mitochondrial cytochrome c oxidase subunits I and II Curr Genet 18 1990 13 15
150. S. Kumar, R. Seqqat, S. Chigurupati, R. Kumar, K.M. Baker, and D. Young Inhibition of nuclear factor kappaB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules Free Radic Biol Med 50 2011 206 215
151. D. Lando, D.J. Peet, J.J. Gorman, D.A. Whelan, M.L. Whitelaw, and R.K. Bruick FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor Genes Dev 16 2002 1466 1471
152. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
153. M. Landriscina, C. Bagala, A. Mandinova, R. Soldi, I. Micucci, and S. Bellum Copper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stress J Biol Chem 276 2001 25549 25557
154. S.C. Leary, P.A. Cobine, B.A. Kaufman, G.H. Guercin, A. Mattman, and J. Palaty The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis Cell Metab 5 2007 9 20
155. S.C. Leary, B.A. Kaufman, G. Pellecchia, G.H. Guercin, A. Mattman, and M. Jaksch Human SCO1 and SCO2 have independent, cooperative functions in copper delivery to cytochrome c oxidase Hum Mol Genet 13 2004 1839 1848
156. S.H. Lee, N. Doliba, M. Osbakken, M. Oz, and D. Mancini Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure J Thorac Cardiovasc Surg 116 1998 344 349
157. J. Lee, M.M. Pena, Y. Nose, and D.J. Thiele Biochemical characterization of the human copper transporter Ctr1 J Biol Chem 277 2002 4380 4387
158. S.H. Li, Y.S. Chun, J.H. Lim, L.E. Huang, and J.W. Park von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase Int J Biochem Cell Biol 43 2011 795 804
159. Q.F. Li, X.Q. Ding, and Y.J. Kang Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor J Nutr Biochem 25 2014 44 49
160. Y. Li, L. Wang, D.A. Schuschke, Z. Zhou, J.T. Saari, and Y.J. Kang Marginal dietary copper restriction induces cardiomyopathy in rats J Nutr 135 2005 2130 2136
161. S. Li, H. Xie, and Y.J. Kang Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway Exp Biol Med (Maywood) 237 2012 77 82
162. R. Liebes, and D.M. Medeiros Decreased nuclear encoded subunits of cytochrome c oxidase and increased copper, zinc-superoxide dismutase activity are found in cardiomyopathic human hearts Int J Cardiol 62 1997 259 267
163. M.T. Lin, and Y.L. Chen Effect of copper ion on collagenase release. Its implication in corneal vascularization Invest Ophthalmol Vis Sci 33 1992 558 563
164. M. Linnebank, H. Lutz, E. Jarre, S. Vielhaber, C. Noelker, and E. Struys Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells Neurobiol Dis 23 2006 725 730
165. J. Lu, X. Wang, W. Wang, H. Muniyappa, C. Hu, and S. Mitra LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse Gene Ther 19 2012 522 531
166. D.T. Lucas, P. Aryal, L.I. Szweda, W.J. Koch, and L.A. Leinwand Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol 284 2003 H575 H583
167. J. Luo, J.R. McMullen, C.L. Sobkiw, L. Zhang, A.L. Dorfman, and M.C. Sherwood Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy Mol Cell Biol 25 2005 9491 9502
168. T. Maciag, G.A. Hoover, M.B. Stemerman, and R. Weinstein Serial propagation of human endothelial cells in vitro J Cell Biol 91 1981 420 426
169. P.C. Mahon, K. Hirota, and G.L. Semenza FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev 15 2001 2675 2686
170. M.R. Malinow, A.G. Bostom, and R.M. Krauss Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 99 1999 178 182
171. D.L. Mann Mechanisms and models in heart failure: a combinatorial approach Circulation 100 1999 999 1008
172. M.A. Mansoor, C. Bergmark, S.J. Haswell, I.F. Savage, P.H. Evans, and R.K. Berge Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease Clin Chem 46 2000 385 391
173. J. Marin-Garcia, M.J. Goldenthal, R. Ananthakrishnan, M.E. Pierpont, F.J. Fricker, and S.E. Lipshultz Mitochondrial function in children with idiopathic dilated cardiomyopathy J Inherit Metab Dis 19 1996 309 312
174. J. Marin-Garcia, M.J. Goldenthal, and G.W. Moe Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure Cardiovasc Res 52 2001 103 110
175. J. Marin-Garcia, M.J. Goldenthal, M.E. Pierpont, and R. Ananthakrishnan Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis J Card Fail 1 1995 285 291
176. F. Martin, T. Linden, D.M. Katschinski, F. Oehme, I. Flamme, and C.K. Mukhopadhyay Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation Blood 105 2005 4613 4619
177. L.J. Martins, L.T. Jensen, J.R. Simon, G.L. Keller, and D.R. Winge Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae J Biol Chem 273 1998 23716 23721
178. B.M. Massie What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians J Card Fail 8 2002 197 201
179. P. Maxwell, and K. Salnikow HIF-1: an oxygen and metal responsive transcription factor Cancer Biol Ther 3 2004 29 35
180. B.R. McAuslan, and G.A. Gole Cellular and molecular mechanisms in angiogenesis Trans Ophthalmol Soc U K 100 1980 354 358
181. B.R. McAuslan, and W. Reilly Endothelial cell phagokinesis in response to specific metal ions Exp Cell Res 130 1980 147 157
182. B.R. McAuslan, W.G. Reilly, G.N. Hannan, and G.A. Gole Angiogenic factors and their assay: activity of formyl methionyl leucyl phenylalanine, adenosine diphosphate, heparin, copper, and bovine endothelium stimulating factor Microvasc Res 26 1983 323 338
183. P.M. McKie, A. Cataliotti, B.D. Lahr, F.L. Martin, M.M. Redfield, and K.R. Bailey The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects J Am Coll Cardiol 55 2010 2140 2147
184. J.R. McMullen, M.C. Sherwood, O. Tarnavski, L. Zhang, A.L. Dorfman, and T. Shioi Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload Circulation 109 2004 3050 3055
185. K.N. Meadows, P. Bryant, and K. Pumiglia Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation J Biol Chem 276 2001 49289 49298
186. D.M. Medeiros, D. Bagby, G. Ovecka, and R. McCormick Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats J Nutr 121 1991 815 824
187. D.M. Medeiros, J. Davidson, and J.E. Jenkins A unified perspective on copper deficiency and cardiomyopathy Proc Soc Exp Biol Med 203 1993 262 273
188. D.M. Medeiros, Z. Liao, and R.L. Hamlin Copper deficiency in a genetically hypertensive cardiomyopathic rat: electrocardiogram, functional and ultrastructural aspects J Nutr 121 1991 1026 1034
189. D.M. Medeiros, and R.E. Wildman Newer findings on a unified perspective of copper restriction and cardiomyopathy Proc Soc Exp Biol Med 215 1997 299 313
190. M. Moriguchi, T. Nakajima, H. Kimura, T. Watanabe, H. Takashima, and Y. Mitsumoto The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production Int J Cancer 102 2002 445 452
191. J. Muller-Hocker, A. Johannes, M. Droste, B. Kadenbach, D. Pongratz, and G. Hubner Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome with deficiency of cytochrome-c-oxidase in cardiac and skeletal muscle. An enzymehistochemical-ultra-immunocytochemical-fine structural study in longterm frozen autopsy tissue Virchows Arch B Cell Pathol Incl Mol Pathol 52 1986 353 367
192. H. Nakagami, K.S. Jensen, and J.K. Liao A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms Ann Med 35 2003 398 403
193. G. Narayanan, B.S. R, H. Vuyyuru, B. Muthuvel, and S. Konerirajapuram Natrajan CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells PLoS ONE 8 2013 e71982
194. S. Neubauer The failing heart - an engine out of fuel N Engl J Med 356 2007 1140 1151
195. R.F. Nicosia, E. Bonanno, and M. Smith Fibronectin promotes the elongation of microvessels during angiogenesis in vitro J Cell Physiol 154 1993 654 661
196. M.L. Nishio, O.I. Ornatsky, E.E. Craig, and D.A. Hood Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats Can J Physiol Pharmacol 73 1995 630 637
197. T. Nittis, G.N. George, and D.R. Winge Yeast Sco1, a protein essential for cytochrome c oxidase function is a Cu(I)-binding protein J Biol Chem 276 2001 42520 42526
198. P. Nyberg, L. Xie, and R. Kalluri Endogenous inhibitors of angiogenesis Cancer Res 65 2005 3967 3979
199. T. Obayashi, K. Hattori, S. Sugiyama, M. Tanaka, T. Tanaka, and S. Itoyama Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy Am Heart J 124 1992 1263 1269
200. T.V. O'Halloran, and V.C. Culotta Metallochaperones, an intracellular shuttle service for metal ions J Biol Chem 275 2000 25057 25060
201. H. Okuyama, B. Krishnamachary, Y.F. Zhou, H. Nagasawa, M. Bosch-Marce, and G.L. Semenza Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1 J Biol Chem 281 2006 15554 15563
202. G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, and J.A. Nitahara Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
203. A.K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh VEGF receptor signalling - in control of vascular function Nat Rev Mol Cell Biol 7 2006 359 371
204. J.F. O'Rourke, Y.M. Tian, P.J. Ratcliffe, and C.W. Pugh Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor-1alpha J Biol Chem 274 1999 2060 2071
205. C. Oswald Mitochondrial copper homeostasis in mammalian cells 2010
206. C. Oswald, U. Krause-Buchholz, and G. Rodel Knockdown of human COX17 affects assembly and supramolecular organization of cytochrome c oxidase J Mol Biol 389 2009 470 479
207. H. Ozaki, H. Hayashi, S.A. Vinores, Y. Moromizato, P.A. Campochiaro, and K. Oshima Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates Exp Eye Res 64 1997 505 517
208. Q. Pan, C.G. Kleer, K.L. van Golen, J. Irani, K.M. Bottema, and C. Bias Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Cancer Res 62 2002 4854 4859
209. K. Pandya, H.S. Kim, and O. Smithies Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo Proc Natl Acad Sci U S A 103 2006 16864 16869
210. L.C. Papadopoulou, C.M. Sue, M.M. Davidson, K. Tanji, I. Nishino, and J.E. Sadlock Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene Nat Genet 23 1999 333 337
211. C.R. Partridge, J.R. Hawker Jr., and R. Forough Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration J Cell Biochem 78 2000 487 499
212. R. Patel, S.F. Nagueh, N. Tsybouleva, M. Abdellatif, S. Lutucuta, and H.A. Kopelen Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation 104 2001 317 324
213. + cells identifies a population of functional endothelial precursors Blood 95 2000 952 958
214. M.M. Pena, S. Puig, and D.J. Thiele Characterization of the Saccharomyces cerevisiae high affinity copper transporter Ctr3 J Biol Chem 275 2000 33244 33251
215. L.K. Phng, and H. Gerhardt Angiogenesis: a team effort coordinated by notch Dev Cell 16 2009 196 208
216. J.R. Prohaska Biochemical changes in copper deficiency J Nutr Biochem 1 1990 452 461
217. J.R. Prohaska, and L.J. Heller Mechanical properties of the copper-deficient rat heart J Nutr 112 1982 2142 2150
218. I. Prudovsky, C. Bagala, F. Tarantini, A. Mandinova, R. Soldi, and S. Bellum The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export J Cell Biol 158 2002 201 208
219. L. Qiu, X. Ding, Z. Zhang, and Y.J. Kang Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1 J Pharmacol Exp Ther 342 2012 561 567
220. A.F. Quigley, R.M. Kapsa, D. Esmore, G. Hale, and E. Byrne Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy J Card Fail 6 2000 47 55
221. N.B. Radford, B. Wan, A. Richman, L.S. Szczepaniak, J.-L. Li, and K. Li Cardiac dysfunction in mice lacking cytochrome-c oxidase subunit VIaH Am J Physiol Heart Circ Physiol 282 2002 H726 H733
222. N. Rahimi, V. Dayanir, and K. Lashkari Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells J Biol Chem 275 2000 16986 16992
223. K.S. Raju, G. Alessandri, M. Ziche, and P.M. Gullino Ceruloplasmin, copper ions, and angiogenesis J Natl Cancer Inst 69 1982 1183 1188
224. B.G. Redman, P. Esper, Q. Pan, R.L. Dunn, H.K. Hussain, and T. Chenevert Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer Clin Cancer Res 9 2003 1666 1672
225. S. Reiser, J.C. Smith Jr., W. Mertz, J.T. Holbrook, D.J. Scholfield, and A.S. Powell Indices of copper status in humans consuming a typical American diet containing either fructose or starch Am J Clin Nutr 42 1985 242 251
226. N.J. Robinson, and D.R. Winge Copper metallochaperones Annu Rev Biochem 79 2010 537 562
227. A. Roguin, S. Nitecki, I. Rubinstein, E. Nevo, A. Avivi, and N.S. Levy Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model Cardiovasc Diabetol 2 2003 18
228. M.G. Rosca, E.J. Vazquez, J. Kerner, W. Parland, M.P. Chandler, and W. Stanley Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation Cardiovasc Res 80 2008 30 39
229. J. Sadoshima, and S. Izumo Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy Circ Res 77 1995 1040 1052
230. S. Saito, G. Matsumiya, T. Sakaguchi, S. Miyagawa, T. Yamauchi, and T. Kuratani Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist J Heart Lung Transplant 29 2010 672 679
231. S. Salceda, and J. Caro Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes J Biol Chem 272 1997 22642 22647
232. M. Salzberg, and E. Muller Quality requirements in clinical studies: a necessary burden? Swiss Med Wkly 133 2003 429 432
233. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, and Y. Qin p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
234. M. Saraste Structural features of cytochrome oxidase Q Rev Biophys 23 1990 331 366
235. J.L. Sartoretto, B.Y. Jin, M. Bauer, F.B. Gertler, R. Liao, and T. Michel Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart Am J Physiol Heart Circ Physiol 297 2009 H1697 H1710
236. R.F. Schmidt, G. Thews, and M.A. Biederman-Thorson Human Physiology 1989 Springer-Verlag Berlin
237. C.J. Schofield, and Z. Zhang Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes Curr Opin Struct Biol 9 1999 722 731
238. M. Schulze, and G. Rodel SCO1, a yeast nuclear gene essential for accumulation of mitochondrial cytochrome c oxidase subunit II Mol Gen Genet 211 1988 492 498
239. K. Schwarz, N. Siddiqi, S. Singh, C.J. Neil, D.K. Dawson, and M.P. Frenneaux The breathing heart - mitochondrial respiratory chain dysfunction in cardiac disease Int J Cardiol 171 2014 134 143
240. L. Seetharam, N. Gotoh, Y. Maru, G. Neufeld, S. Yamaguchi, and M. Shibuya A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF Oncogene 10 1995 135 147
241. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 2003 721 732
242. G.L. Semenza, B.H. Jiang, S.W. Leung, R. Passantino, J.P. Concordet, and P. Maire Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 J Biol Chem 271 1996 32529 32537
243. G.L. Semenza, and N.R. Prabhakar HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia Antioxid Redox Signal 9 2007 1391 1396
244. C.K. Sen, S. Khanna, M. Venojarvi, P. Trikha, E.C. Ellison, and T.K. Hunt Copper-induced vascular endothelial growth factor expression and wound healing Am J Physiol Heart Circ Physiol 282 2002 H1821 H1827
245. V.G. Sharov, A.V. Todor, N. Silverman, S. Goldstein, and H.N. Sabbah Abnormal mitochondrial respiration in failed human myocardium J Mol Cell Cardiol 32 2000 2361 2367
246. G.S. Shields, W.F. Coulson, D.A. Kimball, W.H. Carnes, G.E. Cartwright, and M.M. Wintrobe Studies on copper metabolism. 32. Cardiovascular lesions in copper-deficient swine Am J Pathol 41 1962 603 621
247. N. Shimojo, S. Jesmin, S. Zaedi, T. Otsuki, S. Maeda, and N. Yamaguchi Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol 293 2007 H474 H481
248. Y. Shing, J. Folkman, R. Sullivan, C. Butterfield, J. Murray, and M. Klagsbrun Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor Science 223 1984 1296 1299
249. T. Shioi, J.R. McMullen, P.M. Kang, P.S. Douglas, T. Obata, and T.F. Franke Akt/protein kinase B promotes organ growth in transgenic mice Mol Cell Biol 22 2002 2799 2809
250. T. Shioi, J.R. McMullen, O. Tarnavski, K. Converso, M.C. Sherwood, and W.J. Manning Rapamycin attenuates load-induced cardiac hypertrophy in mice Circulation 107 2003 1664 1670
251. I. Shiojima, K. Sato, Y. Izumiya, S. Schiekofer, M. Ito, and R. Liao Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure J Clin Invest 115 2005 2108 2118
252. I. Shiraishi, J. Melendez, Y. Ahn, M. Skavdahl, E. Murphy, and S. Welch Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes Circ Res 94 2004 884 891
253. X. Shu, W. Wu, R.D. Mosteller, and D. Broek Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases Mol Cell Biol 22 2002 7758 7768
254. N. Shukla, G.D. Angelini, and J.Y. Jeremy Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein Ann Thorac Surg 84 2007 43 49
255. K.-G. Shyu, J.-Y. Liou, B.-W. Wang, W.-J. Fang, and H. Chang Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart 12 2005
256. K.-G. Shyu, J.-Y. Liou, B.-W. Wang, W.-J. Fang, and H. Chang Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart J Biomed Sci 12 2005 409 420
257. J.S. Silvestre, R. Tamarat, T.G. Ebrahimian, A. Le-Roux, M. Clergue, and F. Emmanuel Vascular endothelial growth factor-B promotes in vivo angiogenesis Circ Res 93 2003 114 123
258. C. Skurk, Y. Izumiya, H. Maatz, P. Razeghi, I. Shiojima, and M. Sandri The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling J Biol Chem 280 2005 20814 20823
259. F. Soncin, J.D. Guitton, T. Cartwright, and J. Badet Interaction of human angiopoietin with copper modulates angiopoietin binding to endothelial cells Biochem Biophys Res Commun 236 1997 604 610
260. Y.-H. Song, S. Gehmert, S. Sadat, K. Pinkernell, X. Bai, and N. Matthias VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes Biochem Biophys Res Commun 354 2007 999 1003
261. D.J. Stewart, M.J. Kutryk, D. Fitchett, M. Freeman, N. Camack, and Y. Su VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial Mol Ther 17 2009 1109 1115
262. B. Strilic, T. Kucera, J. Eglinger, M.R. Hughes, K.M. McNagny, and S. Tsukita The molecular basis of vascular lumen formation in the developing mouse aorta Dev Cell 17 2009 505 515
263. L.A. Sturtz, K. Diekert, L.T. Jensen, R. Lill, and V.C. Culotta A fraction of yeast Cu, Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage J Biol Chem 276 2001 38084 38089
264. M. Subramanian, A.L. Hunt, G.A. Petrucci, Z. Chen, E.D. Hendley, and B.M. Palmer Differential metal content and gene expression in rat left ventricular hypertrophy due to hypertension and hyperactivity J Trace Elem Med Biol 28 2014 311 316
265. M. Sun, X. Zuo, R. Li, T. Wang, and Y.J. Kang Vascular endothelial growth factor recovers suppressed cytochrome c oxidase activity by restoring copper availability in hypertrophic cardiomyocytes Exp Biol Med (Maywood) 2014 10.1177/1535370214541910
266. C. Suri, J. McClain, G. Thurston, D.M. McDonald, H. Zhou, and E.H. Oldmixon Increased vascularization in mice overexpressing angiopoietin-1 Science 282 1998 468 471
267. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, and M. Kearney Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 1999 434 438
268. N. Takahashi, Y. Seko, E. Noiri, K. Tobe, T. Kadowaki, and H. Sabe Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes Circ Res 84 1999 1194 1202
269. T. Takahashi, H. Ueno, and M. Shibuya VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells Oncogene 18 1999 2221 2230
270. G. Takemura, M. Kanoh, S. Minatoguchi, and H. Fujiwara Cardiomyocyte apoptosis in the failing heart - a critical review from definition and classification of cell death Int J Cardiol 167 2013 2373 2386
271. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, and E.R. Rodriguez Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat Med 11 2005 214 222
272. K.M. Tang, G.R. Wang, P. Lu, R.H. Karas, M. Aronovitz, and S.P. Heximer Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure Nat Med 9 2003 1506 1512
273. J.C. Tardiff, T.E. Hewett, S.M. Factor, K.L. Vikstrom, J. Robbins, and L.A. Leinwand Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects Am J Physiol Heart Circ Physiol 278 2000 H412 H419
274. M.J. Tolentino, J.W. Miller, E.S. Gragoudas, F.A. Jakobiec, E. Flynn, and K. Chatzistefanou Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate Ophthalmology 103 1996 1820 1828
275. P. Trumbo, A.A. Yates, S. Schlicker, and M. Poos Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc J Am Diet Assoc 101 2001 294 301
276. C.M. Tsen, C.C. Hsieh, C.H. Yen, and Y.T. Lau Homocysteine altered ROS generation and NO accumulation in endothelial cells Chin J Physiol 46 2003 129 136
277. T. Tsukihara, H. Aoyama, E. Yamashita, T. Tomizaki, H. Yamaguchi, and K. Shinzawa-Itoh Structures of metal sites of oxidized bovine heart cytochrome c oxidase at 2.8 A Science 269 1995 1069 1074
278. T. Tsukihara, H. Aoyama, E. Yamashita, T. Tomizaki, H. Yamaguchi, and K. Shinzawa-Itoh The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A Science 272 1996 1136 1144
279. C. Ulyatt, J. Walker, and S. Ponnambalam Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells Biochem Biophys Res Commun 404 2011 774 779
280. M. van Bilsen, P.J. Smeets, A.J. Gilde, and G.J. van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61 2004 218 226
281. D. van Heerden, A. Vosloo, and M. Nikinmaa Effects of short-term copper exposure on gill structure, metallothionein and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in rainbow trout (Oncorhynchus mykiss) Aquat Toxicol 69 2004 271 280
282. K.E. Viestenz, and L.M. Klevay A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency Am J Clin Nutr 35 1982 258 266
283. J. Waltenberger, L. Claesson-Welsh, A. Siegbahn, M. Shibuya, and C.H. Heldin Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J Biol Chem 269 1994 26988 26995
284. B. Wang, D. Dong, and Y.J. Kang Copper chaperone for superoxide dismutase-1 transfers copper to mitochondria but does not affect cytochrome c oxidase activity Exp Biol Med (Maywood) 238 2013 1017 1023
285. T. Wang, R. Li, C. Lin, M. Sun, and Y.J. Kang Brief communication: copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy Exp Biol Med (Maywood) 239 2014 948 953
286. G.L. Wang, and G.L. Semenza Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia J Biol Chem 268 1993 21513 21518
287. G.L. Wang, and G.L. Semenza Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction Blood 82 1993 3610 3615
288. G.L. Wang, and G.L. Semenza General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia Proc Natl Acad Sci U S A 90 1993 4304 4308
289. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 270 1995 1230 1237
290. G.L. Wang, and G.L. Semenza Molecular basis of hypoxia-induced erythropoietin expression Curr Opin Hematol 3 1996 156 162
291. R.M. Wanner, P. Spielmann, D.M. Stroka, G. Camenisch, I. Camenisch, and A. Scheid Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation Blood 96 2000 1558 1565
292. C.M. Warren, and M.L. Iruela-Arispe Signaling circuitry in vascular morphogenesis Curr Opin Hematol 17 2010 213 218
293. N. Weissman, G.S. Shields, and W.H. Carnes Cardiovascular studies on copper-deficient swine. IV. Content and solubility of the aortic elastin, collagen, and hexosamine J Biol Chem 238 1963 3115 3118
294. R.H. Wenger Mammalian oxygen sensing, signalling and gene regulation J Exp Biol 203 2000 1253 1263
295. J. Wikman-Coffelt, W.W. Parmley, and D.T. Mason The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development Circ Res 45 1979 697 707
296. R.E. Wildman, R. Hopkins, M.L. Failla, and D.M. Medeiros Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat Proc Soc Exp Biol Med 210 1995 43 49
297. K.K. Witte, N.P. Nikitin, A.C. Parker, S. von Haehling, H.-D. Volk, and S.D. Anker The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure Eur Heart J 26 2005 2238 2244
298. K.C. Wollert, B. Fiedler, S. Gambaryan, A. Smolenski, J. Heineke, and E. Butt Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes Hypertension 39 2002 87 92
299. C. Wu, L. Yan, C. Depre, S.K. Dhar, Y.-T. Shen, and J. Sadoshima Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction Am J Physiol Cell Physiol 297 2009 C928 C934
300. B. Yang, D. Liu, C.Z. Li, F.Y. Liu, Y.M. Peng, and Y.S. Jiang 1-Methylhydantoin cytotoxicity on renal proximal tubular cells in vitro Ren Fail 29 2007 1025 1029
301. D. Yoshida, Y. Ikeda, and S. Nakazawa Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion Neurol Med Chir (Tokyo) 35 1995 133 135
302. J. Yoshii, H. Yoshiji, S. Kuriyama, Y. Ikenaka, R. Noguchi, and H. Okuda The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells Int J Cancer 94 2001 768 773
303. A. Zafeiridis, V. Jeevanandam, S.R. Houser, and K.B. Margulies Regression of cellular hypertrophy after left ventricular assist device support Circulation 98 1998 656 662
304. M. Zeeb, B. Strilic, and E. Lammert Resolving cell-cell junctions: lumen formation in blood vessels Curr Opin Cell Biol 22 2010 626 632
305. H. Zeng, H.F. Dvorak, and D. Mukhopadhyay Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways J Biol Chem 276 2001 26969 26979
306. L. Zentilin, U. Puligadda, V. Lionetti, S. Zacchigna, C. Collesi, and L. Pattarini Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction FASEB J 24 2010 1467 1478
307. M. Zeviani, D.H. Van Dyke, S. Servidei, S.C. Bauserman, E. Bonilla, and E.T. Beaumont Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency Arch Neurol 43 1986 1198 1202
308. S. Zhang, H. Liu, G.V. Amarsingh, C.C. Cheung, S. Hogl, and U. Narayanan Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation Cardiovasc Diabetol 13 2014 100
309. Z. Zhang, K.G. Neiva, M.W. Lingen, L.M. Ellis, and J.E. Nor VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2 Cell Death Differ 17 2010 499 512
310. Z. Zhang, L. Qiu, C. Lin, H. Yang, H. Fu, and R. Li Copper-dependent and -independent hypoxia-inducible factor-1 regulation of gene expression Metallomics 2014 10.1039/C4MT00052H
311. L. Zhang, M.-L. Ward, A. Phillips, S. Zhang, J. Kennedy, and B. Barry Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats Cardiovasc Diabetol 12 2013 123
312. Y. Zhou, K. Bourcy, and Y.J. Kang Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway Cardiovasc Res 84 2009 54 63
313. Y. Zhou, Y. Jiang, and Y.J. Kang Copper inhibition of hydrogen peroxide-induced hypertrophy in embryonic rat cardiac H9c2 cells Exp Biol Med (Maywood) 232 2007 385 389
314. Y. Zhou, Y. Jiang, and Y.J. Kang Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size J Mol Cell Cardiol 45 2008 106 117
315. M. Ziche, J. Jones, and P.M. Gullino Role of prostaglandin E1 and copper in angiogenesis J Natl Cancer Inst 69 1982 475 482
316. D. Zisa, A. Shabbir, M. Mastri, G. Suzuki, and T. Lee Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells Am J Physiol Regul Integr Comp Physiol 297 2009 R1503 R1515
317. X. Zuo, D. Dong, M. Sun, H. Xie, and Y.J. Kang Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes PLoS ONE 8 2013 e67549
318. X. Zuo, H. Xie, D. Dong, N. Jiang, H. Zhu, and Y.J. Kang Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy Cardiovasc Toxicol 10 2010 208 215